Shuai Chen1, Haining Huang2, Shujin He3, Wei Wang1, Ran Zhao1, Lei Li1, Zhihong Cui4, Renya Zhang1. 1. Department of Pathology, Affiliated Hospital of Jining Medical University Jining, Shandong Province, P. R. China. 2. Department of Pharmacy, Affiliated Hospital of Jining Medical University Jining, Shandong Province, P. R. China. 3. Clinical College, Jining Medical University Jining, Shandong Province, P. R. China. 4. Department of Pathology, The Second People's Hospital of Jining Jining, Shandong Province, P. R. China.
Abstract
OBJECTIVE: In view of the existence of multifarious pathologic subtypes of spindle cell lipoma (SCL), which is easily misdiagnosed as other benign and malignant soft tissue tumors, we performed this study and aimed to better define the category of SCL. METHODS: We collected and analyzed 40 cases of SCL with complete clinical and pathologic information from January 2010 to December 2018. Clinical and histopathologic analyses of SCL were performed, as well as immunohistochemical staining and fluorescence in situ hybridization (FISH) using probes for RB1 and MDM2, and the related literature was reviewed. RESULTS: In 40 cases, the male to female ratio was 3.4:1, and the mean age was 54 years old. SCL of our study included six pathologic subtypes: classic (25/40), fibrous (4/40), myxoid (4/40), low-fat (3/40), pseudoangiomatous (2/40), and fat-rich (2/40) changes. Microscopically, SCL showed distinctive morphology, with uniform spindle cells and a variably adipocytic component. The spindle cells were bland in morphology, without prominent atypia or pleomorphism, set in a myxoid or fibrous matrix. Immunohistochemically, CD34 and vimentin were positive in spindle cells, and spindle cells of 6 cases also expressed S-100 protein. FISH analysis of 10 cases revealed that heterozygous deletion of RB1 was in six samples with chromosome 13 aberrations and MDM2 gene amplification was not detected in any cases. Surgical resection is considered as the primary treatment for SCL, as there was no any recurrence or metastasis in our cases after 2-105 months of follow-up. CONCLUSIONS: SCL is a rare benign lipoma, and the proportion of spindle cells and adipocytic component varies, which may form various pathologic changes. The diagnosis needs to be combined with clinicopathologic features, immunophenotypes, and genetics. It has to be differentiated from mammary-type myofibroblastoma, cellular angiolipoma, solitary fibrous tumor, and myxoid liposarcoma. IJCEP
OBJECTIVE: In view of the existence of multifarious pathologic subtypes of spindle cell lipoma (SCL), which is easily misdiagnosed as other benign and malignant soft tissue tumors, we performed this study and aimed to better define the category of SCL. METHODS: We collected and analyzed 40 cases of SCL with complete clinical and pathologic information from January 2010 to December 2018. Clinical and histopathologic analyses of SCL were performed, as well as immunohistochemical staining and fluorescence in situ hybridization (FISH) using probes for RB1 and MDM2, and the related literature was reviewed. RESULTS: In 40 cases, the male to female ratio was 3.4:1, and the mean age was 54 years old. SCL of our study included six pathologic subtypes: classic (25/40), fibrous (4/40), myxoid (4/40), low-fat (3/40), pseudoangiomatous (2/40), and fat-rich (2/40) changes. Microscopically, SCL showed distinctive morphology, with uniform spindle cells and a variably adipocytic component. The spindle cells were bland in morphology, without prominent atypia or pleomorphism, set in a myxoid or fibrous matrix. Immunohistochemically, CD34 and vimentin were positive in spindle cells, and spindle cells of 6 cases also expressed S-100 protein. FISH analysis of 10 cases revealed that heterozygous deletion of RB1 was in six samples with chromosome 13 aberrations and MDM2 gene amplification was not detected in any cases. Surgical resection is considered as the primary treatment for SCL, as there was no any recurrence or metastasis in our cases after 2-105 months of follow-up. CONCLUSIONS:SCL is a rare benign lipoma, and the proportion of spindle cells and adipocytic component varies, which may form various pathologic changes. The diagnosis needs to be combined with clinicopathologic features, immunophenotypes, and genetics. It has to be differentiated from mammary-type myofibroblastoma, cellular angiolipoma, solitary fibrous tumor, and myxoid liposarcoma. IJCEP
Authors: Jennifer S Ko; Brianne Daniels; Patrick O Emanuel; Paul Elson; Vadim Khachaturov; Jesse K McKenney; John R Goldblum; Steven D Billings Journal: Am J Surg Pathol Date: 2017-09 Impact factor: 6.394
Authors: Alison Cheah; Steven Billings; John Goldblum; Jason Hornick; Nasir Uddin; Brian Rubin Journal: Histopathology Date: 2014-11-25 Impact factor: 5.087
Authors: Nasir Ud Din; Pingchuan Zhang; William R Sukov; Christopher A Sattler; Sarah M Jenkins; Leona A Doyle; Andrew L Folpe; Karen J Fritchie Journal: Am J Clin Pathol Date: 2016-10 Impact factor: 2.493
Authors: José Fernando Val-Bernal; Marta María Mayorga; Natalia Fontanil; Álvaro Terán Journal: Rom J Morphol Embryol Date: 2021 Oct-Dec Impact factor: 0.833